Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans

Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users

(2013) Lynn R. Webster et al.   Drugs in research & development

THC−methadone and THC−naltrexone interactions on discrimination, antinociception, and locomotion in rats

(2011) Alexa A. Wakley et al.   BEHAVIOURAL PHARMACOLOGY

Nicotine and endogenous opioids: Neurochemical and pharmacological evidence

(2010) Maria Hadjiconstantinou et al.   NEUROPHARMACOLOGY

Opioid antagonism enhances marijuana's effects in heavy marijuana smokers

(2010) Ziva D. Cooper et al.   PSYCHOPHARMACOLOGY

Central antinociception induced by µ-opioid receptor agonist morphine, but not δ- or κ-, is mediated by cannabinoid CB1receptor

(2009) Daniela da Fonseca Pacheco et al.   BRITISH JOURNAL OF PHARMACOLOGY

Behavioral sensitization to Δ9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission

(2008) Cristina Cadoni et al.   JOURNAL OF NEUROCHEMISTRY

μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis

(2008) Minoru Hojo et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

(2008) Zuzana Justinova et al.   NEUROPSYCHOPHARMACOLOGY

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

(2008) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

Substitution profile of Δ9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Δ9-tetrahydrocannabinol

(2008) Joshua A. Lile et al.   PSYCHOPHARMACOLOGY

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans

(2008) Deepak Cyril D’Souza et al.   PSYCHOPHARMACOLOGY

Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

(2008) Jun-Xu Li et al.   PSYCHOPHARMACOLOGY

μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

(2006) Carl Rios et al.   BRITISH JOURNAL OF PHARMACOLOGY